The DOI matches its Crossref record; 75 of the 75 references it cites were found in a registry or an index.
TLR9 Expression and Function Is Abolished by the Cervical Cancer-Associated Human Papillomavirus Type 16
Open accessAbstract
Cervical cancer development is linked to the persistent infection by high-risk mucosal human papillomaviruses (HPVs) types. The E6 and E7 major oncoproteins from this dsDNA virus play a key role in the deregulation of the cell cycle, apoptosis, and adaptive immune surveillance. In this study, we show for the first time that HPV type 16 (HPV16), the most carcinogenic type among the high-risk subgroup, interferes with innate immunity by affecting the expression of TLRs. Infection of human primary keratinocytes with HPV16 E6 and E7 recombinant retroviruses inhibits TLR9 transcription and hence functional loss of TLR9-regulated pathways. Similar findings were achieved in HPV16-positive cancer-derived cell lines and primary cervical cancers, demonstrating that this event occurs also in an in vivo context. Interestingly, E6 and E7 from the low-risk HPV type 6 are unable to down-regulate the TLR9 promoter. In addition, E6 and E7 from the high-risk HPV type 18, which are known to persist less competently in the host than HPV16, have reduced efficiency compared with HPV16 in inhibiting TLR9 transcription. Furthermore, a CpG motif derived from the HPV16 E6 DNA sequence activated TLR9, indicating this virus is able to initiate innate responses via the receptor it later down-regulates. This study reveals a novel mechanism used by HPV16 to suppress the host immune response by deregulating the TLR9 transcript, providing evidence that abolishing innate responses may be a crucial step involved in the carcinogenic events mediated by HPVs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Epidemiologic classification of human papillomavirus types associated with cervical cancer
Muñoz, N., Bosch, F. X., de Sanjosé, S., Herrero, R., Castellsagué, X., Shah, K. V., Snijders, P. J. F., & Meijer, C. J. L. M. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021641 · Cited by 6,249
Takeda, K., Kaisho, T., & Akira, S. (2003) · Annual Review of Immunology · doi:10.1146/annurev.immunol.21.120601.141126 · Cited by 6,143
Toll-like receptors: critical proteins linking innate and acquired immunity
Akira, S., Takeda, K., & Kaisho, T. (2001) · Nature Immunology · doi:10.1038/90609 · Cited by 4,777
Papillomaviruses and cancer: from basic studies to clinical application
zur Hausen, H. (2002) · Nature Reviews Cancer · doi:10.1038/nrc798 · Cited by 4,024
Classification of papillomaviruses
de Villiers, E.-M., Fauquet, C., Broker, T. R., Bernard, H.-U., & zur Hausen, H. (2004) · Virology · doi:10.1016/j.virol.2004.03.033 · Cited by 3,193
The global health burden of infection‐associated cancers in the year 2002
Parkin, D. M. (2006) · International Journal of Cancer · doi:10.1002/ijc.21731 · Cited by 2,932
Morgenstern, J. P., & Land, H. (1990) · Nucleic Acids Research · doi:10.1093/nar/18.12.3587 · Cited by 2,101
Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis
Clifford, G. M., Smith, J. S., Plummer, M., Muñoz, N., & Franceschi, S. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6600688 · Cited by 1,561
Inferences, questions and possibilities in Toll-like receptor signalling
Beutler, B. (2004) · Nature · doi:10.1038/nature02761 · Cited by 1,466
Viruses and interferon: a fight for supremacy
Katze, M. G., He, Y., & Gale, M. (2002) · Nature Reviews Immunology · doi:10.1038/nri888 · Cited by 1,419
NATURAL HISTORY OF CERVICAL INTRAEPITHELIAL NEOPLASIA
RICHART, R. M. (1967) · Clinical Obstetrics and Gynecology · doi:10.1097/00003081-196712000-00002 · Cited by 1,376
Natural History of Cervical Intraepithelial Neoplasia: A Critical Review
Östör, A. G. (1993) · International Journal of Gynecological Pathology · doi:10.1097/00004347-199304000-00018 · Cited by 1,260
Therapeutic potential of Toll-like receptor 9 activation
Krieg, A. M. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2059 · Cited by 1,246
Toll-like Receptor 9–mediated Recognition of Herpes Simplex Virus-2 by Plasmacytoid Dendritic Cells
Lund, J., Sato, A., Akira, S., Medzhitov, R., & Iwasaki, A. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030162 · Cited by 1,198
Khan, M. J., Castle, P. E., Lorincz, A. T., Wacholder, S., Sherman, M., Scott, D. R., Rush, B. B., Glass, A. G., & Schiffman, M. (2005) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dji187 · Cited by 1,053
Frisch, M. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.18.1500 · Cited by 885
Guillot, L., Le Goffic, R., Bloch, S., Escriou, N., Akira, S., Chignard, M., & Si-Tahar, M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m410592200 · Cited by 689
The Toll receptor family and microbial recognition
Medzhitov, R., & Janeway, Jr. (2000) · Trends in Microbiology · doi:10.1016/s0966-842x(00)01845-x · Cited by 676
Barton, G. M., Kagan, J. C., & Medzhitov, R. (2006) · Nature Immunology · doi:10.1038/ni1280 · Cited by 670
A46R and A52R from vaccinia virus are antagonists of host IL-1 and toll-like receptor signaling
Bowie, A., Kiss-Toth, E., Symons, J. A., Smith, G. L., Dower, S. K., & O'Neill, L. A. J. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.160027697 · Cited by 466
The carcinogenicity of human papillomavirus types reflects viral evolution
Schiffman, M., Herrero, R., DeSalle, R., Hildesheim, A., Wacholder, S., Cecilia Rodriguez, A., Bratti, M. C., Sherman, M. E., Morales, J., Guillen, D., et al. (2005) · Virology · doi:10.1016/j.virol.2005.04.002 · Cited by 441
Dürst, M., Dzarlieva, R., Boukamp, P., Fusenig, N. E., & Gissmann, L. (1987) · PubMed · Cited by 412
Self-citationImmune evasion in human papillomavirus-associated cervical cancer
Tindle, R. W. (2002) · Nature Reviews Cancer · doi:10.1038/nrc700 · Cited by 399
Sequence motifs in adenoviral DNA block immune activation by stimulatory CpG motifs
Krieg, A. M., Wu, T., Weeratna, R., Efler, S. M., Love-Homan, L., Yang, L., Yi, A.-K., Short, D., & Davis, H. L. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.21.12631 · Cited by 397
Nees, M., Geoghegan, J. M., Hyman, T., Frank, S., Miller, L., & Woodworth, C. D. (2001) · Journal of Virology · doi:10.1128/jvi.75.9.4283-4296.2001 · Cited by 387
Krieg, A. M., Love-Homan, L., Yi, A.-K., & Harty, J. T. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.5.2428 · Cited by 379
Richards, R. M., Lowy, D. R., Schiller, J. T., & Day, P. M. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0508815103 · Cited by 375
Stack, J., Haga, I. R., Schröder, M., Bartlett, N. W., Maloney, G., Reading, P. C., Fitzgerald, K. A., Smith, G. L., & Bowie, A. G. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041442 · Cited by 369
The immunobiology of the TLR9 subfamily
Wagner, H. (2004) · Trends in Immunology · doi:10.1016/j.it.2004.04.011 · Cited by 341
Castle, P. E., Solomon, D., Schiffman, M., & Wheeler, C. M. (2005) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dji186 · Cited by 328
Coffey, R. J., Bascom, C. C., Sipes, N. J., Graves-Deal, R., Weissman, B. E., & Moses, H. L. (1988) · Molecular and Cellular Biology · doi:10.1128/mcb.8.8.3088 · Cited by 322
Growth arrest by the cyclin-dependent kinase inhibitor p27Kip1 is abrogated by c-Myc.
Vlach, J., Hennecke, S., Alevizopoulos, K., Conti, D., & Amati, B. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb01050.x · Cited by 313
Band, V, Zajchowski, D., Kulesa, V, & Sager, R. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.1.463 · Cited by 299
Regulation of Dendritic Cell Function Through Toll-Like Receptors
Kaisho, T., & Akira, S. (2003) · Current Molecular Medicine · doi:10.2174/1566524033479366 · Cited by 288
IFNs activate toll-like receptor gene expression in viral infections
Miettinen, M., Sareneva, T., Julkunen, I., & Matikainen, S. (2001) · Genes & Immunity · doi:10.1038/sj.gene.6363791 · Cited by 282
Yang, K., Puel, A., Zhang, S., Eidenschenk, C., Ku, C.-L., Casrouge, A., Picard, C., von Bernuth, H., Senechal, B., Plancoulaine, S., et al. (2005) · Immunity · doi:10.1016/j.immuni.2005.09.016 · Cited by 272
Zehbe, I., Wilander, E., Delius, H., & Tommasino, M. (1998) · PubMed · Cited by 267
Self-citationGroskreutz, D. J., Monick, M. M., Powers, L. S., Yarovinsky, T. O., Look, D. C., & Hunninghake, G. W. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.3.1733 · Cited by 247
Horsmans, Y., Berg, T., Desager, J.-P., Mueller, T., Schott, E., Fletcher, S. P., Steffy, K. R., Bauman, L. A., Kerr, B. M., & Averett, D. R. (2005) · Hepatology · doi:10.1002/hep.20839 · Cited by 237
de Bouteiller, O., Merck, E., Hasan, U. A., Hubac, S., Benguigui, B., Trinchieri, G., Bates, E. E. M., & Caux, C. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m507163200 · Cited by 220
Self-citationTLR3 and TLR7 Are Targeted to the Same Intracellular Compartments by Distinct Regulatory Elements
Nishiya, T., Kajita, E., Miwa, S., & DeFranco, A. L. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m504951200 · Cited by 217
Hornung, V., Schlender, J., Guenthner-Biller, M., Rothenfusser, S., Endres, S., Conzelmann, K.-K., & Hartmann, G. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.10.5935 · Cited by 205
Woodworth, C. D., Doniger, J., & DiPaolo, J. A. (1989) · Journal of Virology · doi:10.1128/jvi.63.1.159-164.1989 · Cited by 190
The E6 and E7 Proteins of the Cutaneous Human Papillomavirus Type 38 Display Transforming Properties
Caldeira, S., Zehbe, I., Accardi, R., Malanchi, I., Dong, W., Giarrè, M., de Villiers, E.-M., Filotico, R., Boukamp, P., & Tommasino, M. (2003) · Journal of Virology · doi:10.1128/jvi.77.3.2195-2206.2003 · Cited by 190
Self-citationSkiadopoulos, M. H., & McBride, A. A. (1998) · Journal of Virology · doi:10.1128/jvi.72.3.2079-2088.1998 · Cited by 181
Functions of Toll-like receptors: lessons from KO mice
Akira, S., & Takeda, K. (2004) · Comptes Rendus. Biologies · doi:10.1016/j.crvi.2004.04.002 · Cited by 179
Guess, J. C., & McCance, D. J. (2005) · Journal of Virology · doi:10.1128/jvi.79.23.14852-14862.2005 · Cited by 167
Regulation of Dendritic Cell Function Through Toll-like Receptors
Kaisho, T., & Akira, S. (2003) · Current Molecular Medicine · doi:10.2174/1566524033479726 · Cited by 167
Grassmann, K., Rapp, B., Maschek, H., Petry, K. U., & Iftner, T. (1996) · Journal of Virology · doi:10.1128/jvi.70.4.2339-2349.1996 · Cited by 156
Self-citationGheit, T., Landi, S., Gemignani, F., Snijders, P. J. F., Vaccarella, S., Franceschi, S., Canzian, F., & Tommasino, M. (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.02305-05 · Cited by 143
Self-citationMishra, A., Bharti, A. C., Varghese, P., Saluja, D., & Das, B. C. (2006) · International Journal of Cancer · doi:10.1002/ijc.22262 · Cited by 137
Abrogation of IRF-1 response by high-risk HPV E7 protein in vivo
Um, S., Rhyu, J.-W., Kim, E.-J., Jeon, K.-C., Hwang, E.-S., & Park, J. S. (2002) · Cancer Letters · doi:10.1016/s0304-3835(01)00871-0 · Cited by 126
Barbosa, M. S., Vass, W. C., Lowy, D. R., & Schiller, J. T. (1991) · Journal of Virology · doi:10.1128/jvi.65.1.292-298.1991 · Cited by 118
Effect of Suppressive DNA on CpG-Induced Immune Activation
Yamada, H., Gürsel, İ., Takeshita, F., Conover, J., Ishii, K. J., Gürsel, M., Takeshita, S., & Klinman, D. M. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.10.5590 · Cited by 109
Self-citationTranscriptional Regulation of the Human TLR9 Gene
Takeshita, F., Suzuki, K., Sasaki, S., Ishii, N., Klinman, D. M., & Ishii, K. J. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.4.2552 · Cited by 104
Self-citationNardelli‐Haefliger, D., Lurati, F., Wirthner, D., et al. (2005) · Vaccine · doi:10.1016/j.vaccine.2005.02.019 · Cited by 103
Tanabe, M., Kurita-Taniguchi, M., Takeuchi, K., Takeda, M., Ayata, M., Ogura, H., Matsumoto, M., & Seya, T. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2003.09.159 · Cited by 103
Hubert, P., Caberg, J., Gilles, C., Bousarghin, L., Franzen‐Detrooz, E., Boniver, J., & Delvenne, P. (2005) · The Journal of Pathology · doi:10.1002/path.1771 · Cited by 100
Yang, R., Murillo, F., Delannoy, M. J., Blosser, R. L., Yutzy, W. H., Uematsu, S., Takeda, K., Akira, S., Viscidi, R. P., & Roden, R. B. S. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.12.7912 · Cited by 96
Hiller, T., Poppelreuther, S., Stubenrauch, F., & Iftner, T. (2006) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-05-0778 · Cited by 96
Self-citationDistinct toll-like receptor expression in monocytes and T cells in chronic HCV infection
Dolganiuc, A. (2006) · World Journal of Gastroenterology · doi:10.3748/wjg.v12.i8.1198 · Cited by 88
Düesberg, U., Bussche, A. V. D., Kirschning, C. J., Miyake, K., Sauerbruch, T., & Spengler, U. (2002) · Immunology Letters · doi:10.1016/s0165-2478(02)00178-5 · Cited by 84
HPV-18 immortalization of human keratinocytes
Kaur, P., & McDougall, J. K. (1989) · Virology · doi:10.1016/0042-6822(89)90247-x · Cited by 81
Maloney, G., Schröder, M., & Bowie, A. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m501917200 · Cited by 75
The IARC Commitment to Cancer Prevention: The Example of Papillomavirus and Cervical Cancer
Franceschi, S. (2005) · Recent results in cancer research/Recent Results in Cancer Research · doi:10.1007/3-540-26980-0_18 · Cited by 70
Silva, D. M. D., Pastrana, D. V., Schiller, J. T., & Kast, W. M. (2001) · Virology · doi:10.1006/viro.2001.1179 · Cited by 67
Kaneko, T., Moriyama, T., Udaka, K., et al. (1997) · European Journal of Immunology · doi:10.1002/eji.1830270728 · Cited by 66
Fausch, S. C., Fahey, L. M., Da Silva, D. M., & Kast, W. M. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.11.7172 · Cited by 60
Sanghavi, S., & Reinhart, T. A. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.8.5314 · Cited by 55
Differential expression of toll-like receptors 2 and 4 in patients with liver cirrhosis
Manigold, T., Böcker, U., Hanck, C., Gundt, J., Traber, P., Antoni, C., & Rossol, S. (2003) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-200303000-00011 · Cited by 48
Papillomaviruses: a correlation between immune evasion and oncogenicity?
O’Brien, P. M., & Campo, M. S. (2003) · Trends in Microbiology · doi:10.1016/s0966-842x(03)00145-8 · Cited by 43
Yakushijin, T., Kanto, T., Inoue, M., Oze, T., Miyazaki, M., Itose, I., Miyatake, H., Sakakibara, M., Kuzushita, N., Hiramatsu, N., et al. (2006) · Hepatology Research · doi:10.1016/j.hepres.2005.12.010 · Cited by 31
Encyclopedia Reference of Cancer
Schwab, E. M., & Kavanagh, J. J. (2003) · International Journal of Gynecological Cancer · doi:10.1046/j.1525-1438.2003.13195.x · Cited by 29
Differential induction of gene promoter constructs by constitutively active human TLRs
Hasan, U. A., Dollet, S., & Vlach, J. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.06.134 · Cited by 28
Self-citationBernard, B. A., Bailly, C., Lenoir, M.-C., & Darmon, M. Y. (1990) · Journal of Cellular Biochemistry · doi:10.1002/jcb.240420206 · Cited by 12
Cited by
Human papillomavirus and cervical cancer
Burd, E. M. (2003) · Clinical Microbiology Reviews · doi:10.1128/cmr.16.1.1-17.2003 · Cited by 2,420
Human papillomavirus and cervical cancer
Crosbie, E. J., Einstein, M. H., Franceschi, S., & Kitchener, H. C. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60022-7 · Cited by 1,171
Cervical cancer in low and middle‑income countries (Review)
Hull, R., Mbele, M., Makhafola, T., Hicks, C., Wang, S., Reis, R., Mehrotra, R., Mkhize‑Kwitshana, Z., Kibiki, G., Bates, D., et al. (2020) · Oncology Letters · doi:10.3892/ol.2020.11754 · Cited by 544
Cancer Immunotherapy by Dendritic Cells
Melief, C. J. M. (2008) · Immunity · doi:10.1016/j.immuni.2008.08.004 · Cited by 508
Graham, S. V. (2017) · Clinical Science · doi:10.1042/cs20160786 · Cited by 456
Metadata
- Authors
- Hasan, U. A., Bates, E., Takeshita, F., Biliato, A., Accardi, R., Bouvard, V., Mansour, M., Vincent, I., Gissmann, L., Iftner, T., Sideri, M., Stubenrauch, F., & Tommasino, M.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2007-03-01
- Volume
- 178
- Issue
- 5
- Pages
- 3186-3197
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W2143752982
- Cited by
- 380
- References
- 75
- FWCI
- 10.26
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.